SigTuple Raises $4 Mn In Extended Series C Round Led By Sidbi Venture Capital

Medtech startup SigTuple, specialising in digital microscopy solutions powered by artificial intelligence (AI) , on Wednesday, said that it has raised Rs 33 crore (USD 4 million) in an extended series C funding round led by SIDBI Venture Capital, with participation from existing investors including Endiya Partners, and a few strategic leaders from the healthcare sector.

The startup will new funding to drive geographical expansion, expand its product portfolio and support regulatory clearances. 

SigTuple, founded in 2015 by Tathagato Rai Dastidar, uses robots and artificial intelligence (AI) to automate manual microscopic reviews. 

In September 2023, SigTuple received US FDA 510(k) approval for AI100, making it the third company globally, and the first in India, to achieve this for AI-assisted digital hematology. The company is set to launch a next-generation product that automates all manual microscopy in clinical labs, surpassing the AI100. “2024 will witness two new major product launches addressing a wide segment of the diagnostic industry, which will help make SigTuple a global brand coming out of India,” stated Tathagato Rai Dastidar, Founder & CEO - SigTuple.

Additionally, SigTuple is entering the point-of-care market with microfluidic technology and imaging to process essential tests in minutes, promoting decentralization and making quality diagnostics accessible, as per press release.